respons
pathogen
infect
multifacet
employ
innat
adapt
acquir
immun
system
exploit
adapt
immun
system
defenc
viral
infect
use
extens
sinc
edward
jenner
inocul
jame
phipp
cowpox
later
challeng
variol
materi
vaccin
util
adapt
immun
system
mount
specif
immun
respons
aim
diseas
prevent
use
result
erad
certain
diseas
popul
notabl
small
pox
product
effect
vaccin
limit
genet
instabl
lead
revers
attenu
strain
virul
strain
result
infect
vaccin
individu
heat
sensit
vaccin
necessit
requir
refriger
alway
possibl
develop
countri
lack
good
antigen
protein
subunit
vaccin
among
limit
util
innat
immun
system
nonspecif
respond
viral
infect
investig
recent
mucos
surfac
serv
entri
site
major
infecti
pathogen
includ
respiratori
virus
provid
first
line
defenc
infect
earli
stage
infect
immun
respons
nonantigen
specif
involv
natur
killer
nk
natur
killer
nkt
cell
activ
antigen
present
cell
apc
indirectli
respond
danger
signal
deriv
invad
pathogen
certain
conserv
molecular
structur
present
pathogen
pathogenassoci
molecular
pattern
pamp
bacteri
lipoprotein
lipopolysaccharid
recogn
innat
immun
cell
via
pathogen
recognit
receptor
prr
cell
activ
upon
recognit
pamp
prr
trigger
product
cytokin
necessari
develop
effect
immun
tolllik
receptor
tlr
famili
prr
highli
conserv
drosophila
human
human
possess
least
differ
tlr
tlr
consist
extracellular
leucinerich
repeat
cytoplasm
tollinterleukin
il
receptor
tir
homolog
domain
although
tlr
share
structur
function
similar
exhibit
differ
pattern
express
respond
differ
pamp
peptidoglycan
recogn
doublestrand
ds
rna
lipopolysaccharid
singlestrand
ss
rna
unmethyl
deoxycytidyldeoxyguanosinyl
cpg
dinucleotid
upon
detect
viral
infect
prr
dendrit
cell
dc
becom
activ
traffic
lymph
node
present
viral
antigen
induc
product
interferon
ifn
cytokin
induc
cytotox
lymphocyt
ctl
activ
nk
cell
induc
prolifer
cell
includ
treg
cell
activ
cell
activ
virusspecif
b
cell
result
antibodi
product
adapt
immun
respons
influenza
viru
segment
sens
rna
viru
orthomyxovirida
famili
influenza
virus
transmit
primarili
aerosol
inhal
contagi
droplet
gener
sneez
cough
direct
contact
infect
person
influenza
pandem
occur
novel
strain
influenza
viru
caus
sever
epidem
spread
sever
geograph
locat
affect
except
high
proport
popul
locat
past
human
influenza
viru
pandem
caus
influenza
subtyp
recent
year
highli
pathogen
avian
influenza
virus
subtyp
caus
outbreak
poultri
africa
europ
middl
east
asia
north
america
pandem
potenti
fortun
pandem
influenza
strain
caus
rel
mild
diseas
major
peopl
infect
influenza
viru
infect
induc
express
fa
ligand
regul
upon
activ
normal
tcell
express
presum
excret
rant
dsrna
depend
protein
kinas
r
pkr
indolamin
intracellular
adhes
molecul
icam
oligoadenyl
synthetas
also
induc
involv
control
influenza
viru
replic
lung
especi
earli
stage
infect
activ
innat
immun
mechan
includ
ifn
product
nk
cell
activ
produc
cell
specif
influenza
viru
involv
cell
depend
product
nk
cell
suggest
earli
stage
recurr
viral
infect
nkmediat
innat
immun
viru
enhanc
preexist
viru
specif
cell
influenza
viral
infect
induc
necrosi
infect
epitheli
cell
apoptosi
monocytesmacrophag
latter
mediat
either
perforin
regul
pkr
human
dc
captur
dead
cell
contain
influenza
viru
produc
cytokin
undergo
matur
expand
helper
cell
fail
elicit
cytotox
cell
respons
antigen
dead
cell
recent
studi
demonstr
chicken
infect
strain
resist
influenza
viru
challeng
protect
immun
close
relat
percentag
cell
express
lung
rather
spleen
suggest
pulmonari
cellular
immun
may
import
protect
natur
host
lethal
influenza
virus
singlecycl
infect
human
influenza
virus
preferenti
infect
noncili
epitheli
cell
wherea
avian
virus
well
eggadapt
human
viru
variant
avian
viruslik
receptor
specif
primarili
infect
ciliat
cell
correl
predomin
local
receptor
human
sialic
acid
avian
sialic
acid
virus
noncili
ciliat
cell
respect
sialic
acid
link
galactos
via
glycosid
bond
cellular
receptor
locat
eye
may
account
ocular
tropism
exhibit
zoonot
avian
influenza
virus
strain
influenza
viru
result
hyperinduct
proinflammatori
apoptot
cytokin
result
cytokin
storm
may
lead
lung
injuri
multipl
organ
failur
sinc
cytokin
storm
mediat
function
immun
system
normal
immun
system
function
suscept
sever
advers
effect
infect
strain
includ
avian
influenza
signific
differ
cytokin
respons
influenza
virus
primarili
relat
rant
elev
postinfect
pi
human
type
ii
pneumocyt
significantli
infect
cell
recent
virus
vietnam
potent
induc
inactiv
viru
uv
irradi
prior
infect
alveolar
epitheli
cell
abolish
cytokin
induct
suggest
viru
replic
requir
cytokin
induct
influenza
infect
bird
system
character
hemorrhag
pulmonari
edema
result
viru
replic
stimul
vascular
endotheli
growth
factor
alveolar
endothelium
system
infect
also
observ
cynomolgu
macaqu
human
mice
infect
influenza
virusinfect
cell
initi
appear
respiratori
tract
later
could
detect
neuron
glial
ependym
cell
central
nervou
system
influenza
virus
classifi
high
low
pathogen
virus
differ
host
respons
lethal
nonleth
influenza
viru
like
due
viral
nonstructur
ns
protein
bind
dsrna
effect
shield
immun
system
shown
inhibit
apoptosi
rigi
nuclear
transloc
fig
mice
infect
lethal
ahong
influenza
viru
signific
decreas
total
number
circul
leukocyt
primarili
lymphocyt
earli
day
pi
reduct
number
cell
macrophag
inflammatori
protein
mip
lung
lymphoid
tissu
elev
mice
infect
either
lethal
ahong
nonleth
ahong
influenza
viru
although
degre
elev
lower
mice
infect
lethal
strain
wherea
level
elev
similar
manner
strain
suggest
may
contribut
earli
diseas
sever
wherea
may
play
role
viral
clearanc
late
infect
mice
infect
lethal
influenza
viru
also
increas
concentr
brain
apoptosi
spleen
lung
although
infect
mice
show
evid
virusinduc
enceph
local
synthesi
within
brain
could
contribut
anorexia
weight
loss
death
lethal
influenza
viru
appear
possess
capac
limit
induct
immun
respons
target
destroy
lymphocyt
result
aberr
product
cytokin
serum
tissu
addit
cytokin
storm
system
viral
dissemin
alveolar
flood
due
inhibit
cellular
sodium
channel
contribut
lethal
influenza
diseas
rsv
sens
envelop
rna
viru
paramyxovirida
famili
rsv
ubiquit
pathogen
caus
upper
respiratori
infect
healthi
adult
bronchiol
pneumonia
young
children
exacerb
diseas
patient
chronic
obstruct
pulmonari
diseas
asthma
lifethreaten
pneumonia
immunosuppress
patient
rsv
infect
increas
respons
airway
epitheli
cell
subsequ
bacteri
ligand
rigi
respons
earli
recognit
rsv
dsrna
within
hour
infect
import
later
respons
induct
rsv
mediat
rigidepend
secret
infect
airway
epitheli
cell
mediat
ifnstimul
respons
element
isr
signal
transduc
activ
transcript
stat
site
proxim
promot
addit
inhibitor
pkr
demonstr
effect
induct
follow
rsv
infect
signific
differ
follow
polyriboinosinicpolyribocytidyl
acid
poli
ic
treatment
suggest
pkr
play
role
primari
rsvinduc
inflamm
play
role
poli
ic
induc
secondari
inflamm
rsv
protein
block
ifn
signal
stimul
proteasom
degrad
interf
rigi
pathway
fig
rsv
also
inhibit
viralinduc
apoptosi
use
knockout
ko
mice
shown
signal
leukocyt
activ
innat
immun
rsv
induc
chemokin
cc
ligand
ccl
chemoattract
protein
mcp
control
viral
replic
interact
also
promot
neutrophil
migrat
dc
activ
within
lung
microarray
analysi
pulmonari
innat
immun
respons
rsv
demonstr
induct
ifn
cytokin
chemokin
prrrelat
gene
mav
depend
independ
one
day
rsv
infect
wild
type
wt
mice
exhibit
pulmonari
dysfunct
possibl
attribut
inflammatori
cytokin
respons
caus
airway
obstruct
serum
antirsv
antibodi
respons
significantli
attenu
mice
lack
either
mav
reduc
even
doubl
ko
mice
suggest
mav
play
import
role
gener
antirsv
antibodi
contrast
antibodi
product
respons
influenza
depend
mav
independ
coronaviru
cov
nonseg
sens
rna
viru
coronavirida
famili
coronavirus
transmit
aerosol
respiratori
secret
fecalor
rout
mechan
transmiss
viral
growth
occur
epitheli
cell
howev
organ
liver
kidney
heart
eye
cell
type
ie
macrophag
may
occasion
infect
infect
local
epithelium
upper
respiratori
tract
caus
mild
selflimit
diseas
classic
cold
upset
stomach
occasion
caus
enter
infect
primarili
infant
month
rare
caus
neurolog
syndrom
coronaviru
infect
common
children
less
common
adult
occur
worldwid
exhibit
strongli
season
incid
infect
reinfect
recur
throughout
life
impli
multipl
serotyp
least
four
known
andor
antigen
variat
henc
prospect
immun
appear
bleak
sar
form
viral
pneumonia
infect
encompass
lower
respiratori
tract
clinic
symptom
includ
fever
dri
cough
dyspnea
short
breath
headach
hypoxemia
typic
laboratori
find
includ
lymphopenia
mildli
elev
aminotransferas
level
indic
liver
damag
death
may
result
progress
respiratori
failur
due
alveolar
damag
typic
clinic
cours
sar
involv
improv
symptom
first
week
infect
follow
worsen
second
week
studi
indic
worsen
may
relat
patient
immun
respons
rather
uncontrol
viral
replic
tlr
signal
import
sarscov
recognit
innat
immun
system
sinc
mice
resist
sarscov
strain
suscept
genet
delet
sarscov
ineffici
activ
alveolar
macrophag
respiratori
dc
therefor
impair
antivir
respons
product
endocytosi
cell
respons
sarscov
protein
inhibit
translat
variou
cellular
rna
involv
induct
cellular
stress
respons
includ
apoptosi
sarscov
hand
inhibit
apoptosi
thu
facilit
viral
immun
evas
viru
propag
fig
analysi
splenocyt
wt
mice
determin
nont
cell
respons
high
level
present
follow
infect
coronaviru
strain
primarili
infect
liver
brain
high
cytokin
level
could
abrog
addit
cell
celltocel
contact
requir
consequ
would
expect
tcell
lymphocytedefici
mice
infect
strain
exhibit
symptom
cytokin
storm
rhinoviru
nonseg
sens
rna
viru
picornavirida
famili
rhinovirus
growth
optimum
prolifer
ciliat
epithelium
upper
respiratori
tract
damag
cell
result
symptom
predisposit
secondari
bacteri
infect
interestingli
differenti
airway
epitheli
cell
higher
express
increas
resist
rhinoviru
infect
rhinoviru
replic
also
induc
mucin
product
primari
human
epitheli
cell
cell
line
induct
depend
mucin
product
neg
regul
partial
depend
trif
rhinoviru
infect
common
caus
acut
exacerb
inflammatori
lung
diseas
asthma
chronic
obstruct
pulmonari
diseas
provok
steroid
refractori
abnorm
intens
neutrophil
inflamm
life
threaten
rhinoviru
strain
infect
rapidli
promot
induct
epiderm
growth
factor
receptor
egfr
ligand
util
egfr
signal
increas
level
coupl
antivir
defens
machineri
major
epitheli
prolifer
repair
pathway
may
play
import
role
viralinduc
airway
remodel
airway
diseas
exacerb
suggest
target
egfr
may
provid
select
therapi
dampen
neutrophildriven
inflamm
without
compromis
essenti
antivir
pathway
mediat
prr
rhinoviru
replic
increas
express
mrna
protein
cell
surfac
block
lead
decreas
respons
poli
ic
increas
follow
rhinoviru
infect
demonstr
import
function
requir
host
respons
rhinoviru
infect
indic
poli
ic
alway
good
model
studi
biolog
live
viral
infect
suggest
poli
ic
could
util
therapeut
differ
mechan
action
pathway
import
induct
type
ifn
follow
rhinoviru
infect
howev
rhinoviru
abl
inhibit
order
evad
arm
immun
respons
fig
synthet
dsrna
least
base
pair
length
includ
poli
ic
alon
stabil
polyllysin
carboxymethyl
cellulos
poli
iclc
polyadenosinicpolyuridyl
acid
poli
au
use
molecular
mimic
viral
dsrna
compar
studi
mice
use
variou
mimic
determin
ifn
induct
highest
poli
iclc
lowest
poli
au
splenocyt
cytotox
significantli
higher
poli
iclc
poli
au
poli
iclc
shown
upregul
downregul
lung
tissu
treat
mice
signal
pathway
invok
poli
ic
administr
vari
cell
type
respond
intraperiton
ip
administr
poli
ic
wt
trif
ko
ko
doubl
ko
demonstr
serum
induct
depend
primarili
trif
pathway
wherea
induct
entir
depend
trif
pathway
spleen
poli
ic
induct
depend
wherea
rant
depend
trif
dc
product
depend
trif
addit
ko
mice
sever
defect
poli
ic
enhanc
antibodi
product
wherea
trif
ko
mice
display
modestli
reduc
antibodi
product
intestin
epitheli
cell
poli
ic
activ
dimer
phosphoryl
increas
activ
isr
induc
upregul
express
ifnregul
gene
rigi
manner
signal
involv
even
though
express
cell
howev
gender
differ
note
human
rhesu
monkey
male
consist
significantli
higher
ifn
respons
femal
thu
antivir
activ
ifn
andor
activ
nk
cell
induc
dsrna
may
result
nonspecif
antivir
defenc
number
viral
agent
may
therefor
provid
broadspectrum
antivir
effect
virus
regardless
strain
subtyp
drug
resist
poli
ic
andor
poli
iclc
shown
effect
rodent
primat
marin
crustacean
litopenaeu
vannamei
protect
observ
influenza
viru
rift
valley
fever
viru
rabi
viru
punta
toro
viru
herp
simplex
viru
type
western
equin
enceph
viru
venezuelan
equin
encephalomyel
viru
yellow
fever
viru
sarscov
rsv
white
spot
syndrom
viru
taura
syndrom
viru
poli
ic
also
shown
effect
nk
cell
elimin
histolog
lesion
graftversushost
diseas
mice
influenza
protein
sequest
dsrna
bind
rigi
inhibit
downstream
activ
prevent
transcript
induct
fig
thu
poli
ic
way
signal
may
act
overcom
inhibit
mice
prophylact
treatment
two
intranas
dose
mgkgdose
poli
iclc
provid
complet
protect
lethal
influenza
viral
challeng
partial
protect
henan
clade
suggest
poli
ic
add
cytokin
storm
associ
mortal
influenza
virus
mice
given
one
poli
iclc
dose
day
prior
influenza
viral
challeng
second
dose
one
day
prior
challeng
surviv
rate
respect
mice
receiv
liposomeencapsul
poli
iclc
day
prior
viru
challeng
fulli
protect
thu
increas
shortterm
window
prophylaxi
provid
poli
iclc
poli
iclc
may
thu
provid
shortterm
prophylaxi
influenza
suggest
multiday
window
protect
observ
nk
cell
activ
remain
elev
nine
six
day
postpoli
iclc
treatment
liver
bloodspleen
respect
poli
au
also
increas
nk
cell
activ
liver
dose
approxim
higher
use
poli
iclc
requir
treatment
singl
dose
poli
ic
hour
prior
infect
sarscov
protect
mice
lethal
diseas
minim
weight
loss
enhanc
upregul
alveolar
macrophag
gener
earli
robust
antigenspecif
cell
respons
increas
type
ifn
product
even
though
sarscov
moder
sensit
effect
ifn
similarli
poli
iclc
given
hour
prior
rsv
infect
mark
reduct
viral
titr
amelior
clinic
ill
reduc
inflamm
observ
howev
poli
iclc
given
hour
postrsv
exposur
poli
iclc
mediat
product
complet
suppress
poli
iclc
administ
postinfluenza
viru
exposur
also
less
effect
administ
prophylact
mice
treat
two
intraven
iv
dose
mgkgdose
poli
iclc
hour
pi
show
small
increas
surviv
compar
untreat
control
mice
singl
postexposur
treatment
found
almost
complet
ineffect
postexposur
efficaci
shown
mice
infect
punta
toro
viru
west
nile
viru
treatment
start
one
day
prior
infect
continu
everi
hour
day
pi
treatment
delay
hour
viral
challeng
efficaci
greatli
reduc
poli
ic
also
use
adjuv
splitproduct
influenza
vaccin
treatment
vaccin
plu
poli
ic
rapidli
upregul
express
nasalassoci
lymphoid
tissu
upregul
induc
mice
subsequ
challeng
influenza
crossprotect
partial
protect
protect
observ
immun
variou
viru
vaccin
abeij
ayamagata
heterolog
influenza
vaccin
aguizh
influenza
b
vaccin
bibaraki
byamagata
baichi
respect
tcell
activ
increas
product
observ
mice
immun
homolog
antigen
poli
iclc
shown
effect
adjuv
coadminist
retino
acid
vitamin
metabolit
chloroquin
plasmodium
yoelii
nigeriensi
infect
antisemliki
forest
viru
hyperimmun
serum
inhibit
flaviviru
replic
clinic
use
poli
ic
may
one
appropri
agent
gener
stabl
matur
dc
matur
dc
might
gener
vivo
effect
immun
respons
inject
retain
abil
secret
bioactiv
ligat
potenti
poli
iclc
antivir
agent
howev
limit
intrins
toxic
toxic
poli
iclc
affect
rout
administr
subcutan
sc
administr
toler
well
rabbit
mice
unpublish
observ
intratrach
administr
well
toler
mice
intramuscular
im
ip
iv
administr
result
variabl
level
toxic
depend
anim
speci
dose
use
mice
given
three
dose
poli
ic
hour
apart
demonstr
sign
lung
inflamm
increas
neutrophil
bronchioalveolar
lavag
fluid
increas
cytokin
level
cellular
infiltr
lung
decreas
lung
function
milder
reaction
seen
ko
mice
clinic
trial
patient
receiv
multipl
therapeut
dose
poli
iclc
iv
im
exhibit
seriou
toxic
reaction
includ
hypotens
fever
anemia
leukopenia
thrombocytopenia
nausea
inject
site
inflamm
multipl
sclerosi
patient
neurolog
dysfunct
contradictori
result
regard
poli
ic
autoimmun
disord
report
autoimmunepron
mice
mrl
poli
ic
administr
induc
chronic
pancreat
aggrav
lupu
nephriti
upregul
also
report
promot
proinflammatori
autoimmun
respons
islet
destruct
diabet
hepat
diseas
contrast
system
applic
poli
ic
ligand
sensit
phase
abolish
featur
experiment
asthma
includ
airway
hyperrespons
allerg
airway
inflamm
addit
administr
anim
alreadi
establish
primari
allerg
respons
reveal
markedli
reduc
secondari
respons
follow
allergen
aerosol
rechalleng
poli
ic
administr
suppress
immun
complexmedi
experiment
arthriti
mice
suppress
depend
type
ifn
inhibit
synovi
cell
prolifer
inflammatori
cytokin
product
howev
studi
rheumatoid
arthriti
patient
suggest
poli
ic
upregul
express
activ
synovi
fluid
fibroblast
stimul
proinflammatori
gene
express
suggest
rna
releas
necrot
cell
might
act
endogen
ligand
rheumatoid
arthriti
intraarticular
poli
ic
administr
induc
arthriti
mediat
receptor
signal
earli
day
postadministr
thu
potenti
link
tlr
upregul
autoimmun
emphas
need
caution
use
tlr
agonist
new
therapi
vaccin
adjuv
attempt
improv
safeti
efficaci
poli
iclc
focus
optim
dosag
treatment
regim
encapsul
within
liposom
modif
poli
iclc
coadministr
agent
mitig
cytokinemedi
advers
reaction
patient
advanc
cancer
optim
poli
iclc
administr
regim
found
administ
alternateday
schedul
gradual
dose
escal
studi
maximum
toler
dose
vari
sever
hundredfold
dose
rang
mice
poli
iclc
administr
result
loss
total
bodi
weight
hypothermia
encapsul
poli
iclc
within
cation
liposom
compos
phosphatidylcholin
cholesterol
stearylamin
complet
mitig
toxic
determin
absenc
weight
loss
chang
bodi
temperatur
observ
free
poli
iclc
administ
iv
liposomeencapsul
poli
iclc
reduc
weight
loss
follow
administr
reduc
magnitud
durat
bodi
temperatur
reduct
follow
influenza
infect
liposom
shown
accumul
site
infect
possibl
concentr
encapsul
drug
diseas
site
therebi
minim
exposur
healthi
organ
tissu
drug
result
gradual
sustain
releas
poli
iclc
therebi
avoid
rapid
system
elev
drug
level
observ
rout
administr
unclear
whether
signific
reduct
toxic
poli
iclc
provid
liposom
result
correspond
decreas
clinic
side
effect
seen
human
patient
modifi
poli
ic
result
variabl
success
modif
includ
use
lower
molecular
weight
molecul
thiolat
rabbit
low
molecular
weight
poli
iclc
induc
high
ifn
respons
amelior
hypotens
respons
howev
also
induc
high
fever
optim
antivir
antiprolif
activ
observ
thiolat
five
posit
cytosin
base
poli
c
strand
result
suggest
studi
modif
poli
iclc
may
advantag
elimin
reduct
toxic
side
effect
mitig
cytokinemedi
advers
reaction
hydrocortison
treatment
prior
follow
iv
poli
iclc
administr
reduc
hypotens
respons
ifn
induct
rabbit
signal
pathway
stimul
poli
iclc
implic
increas
plasma
concentr
male
rat
given
receptor
agonist
prior
poli
ic
administr
elev
plasma
concentr
reduct
fever
human
highli
pathogen
influenza
hpia
viru
mediat
cytokin
storm
character
hypercytokinemia
uncontrol
product
rant
numer
chemokin
lung
mice
decreas
cell
apoptosi
lymphocyt
spleen
lung
detect
cytokin
brain
associ
influenza
patholog
furthermor
protein
hpia
viru
inhibit
gener
ifn
signal
pathway
thu
mediat
evas
host
antivir
ifnmedi
defenc
theoret
nonspecif
immun
stimul
effect
influenza
viral
infect
overcom
insensit
ifn
prevent
apoptosi
lymphocyt
without
contribut
cytokin
dysregul
prevent
apoptosi
cell
could
potenti
increas
prefer
would
induc
nonspecif
immun
stimul
alreadi
highli
induc
influenza
viral
infect
although
mice
defici
receptor
reduct
mortal
infect
avietnam
suggest
alon
respons
increas
mortal
influenza
virus
inhibit
cytokin
respons
corticosteron
natur
mous
glucocorticoid
suffici
prevent
death
regardless
drug
administ
suggest
factor
cytokin
storm
import
lethal
treatment
mice
liposomeencapsul
poli
iclc
evalu
efficaci
influenza
mice
given
one
lethal
dose
viru
surviv
rate
wherea
given
two
dose
liposomeencapsul
poli
iclc
surviv
rate
viru
dose
increas
surviv
treat
mice
decreas
wherea
untreat
mice
succumb
infect
demonstr
nonspecif
immun
stimul
may
effect
prophylaxi
pandem
strain
influenza
similar
influenza
viru
rsv
also
poor
induc
partial
resist
ifn
antivir
activ
poli
iclc
induc
given
rsv
infect
mice
milder
diseas
faster
recoveri
increas
ifn
product
reduc
viral
replic
howev
poli
iclc
administ
hour
postrsv
infect
product
almost
complet
inhibit
innat
adapt
immun
system
affect
age
innat
immun
system
function
nk
cell
macrophag
fewer
number
less
effici
antigen
present
neutrophil
impair
chemotaxi
degranul
phagocytosi
decreas
age
agerel
chang
adapt
immun
system
includ
diminishedalt
cytokin
pattern
bia
reduct
clonal
expans
function
antigenspecif
b
cell
declin
antigenpres
cell
function
humor
immun
also
exhibit
chang
albeit
lesser
extent
particularli
diminish
abil
gener
highaffin
protect
antibodi
infecti
agent
splenic
activ
periton
macrophag
age
mice
express
significantli
lower
level
tlr
macrophag
age
mice
secret
significantli
lower
level
stimul
known
tlr
ligand
poli
iclc
abl
effect
protect
age
mice
lethal
murin
cytomegaloviru
infect
effect
induc
ifn
similarli
sever
combin
immunodefici
scid
mice
almost
complet
protect
murin
cytomegaloviru
infect
poli
iclc
poli
iclc
abl
induc
ifn
nk
cell
cytotox
mice
result
suggest
although
receptor
reduc
age
process
poli
iclc
still
potenti
effect
light
current
concern
regard
viralinduc
cytokin
storm
poli
iclc
appear
potenti
stimul
innat
immun
system
thu
provid
protect
poli
iclc
stimul
would
theoret
effect
adjuv
gener
crossprotect
antibodi
thu
expand
number
peopl
could
immun
use
poli
iclc
adjuv
requir
lower
dose
use
sole
prophylaxi
thu
allevi
toxic
concern
associ
use
agonist
appear
effect
use
prophylact
varieti
viral
agent
evalu
agent
trigger
cytokin
storm
host
influenza
sar
improv
surviv
observ
suggest
agonist
contribut
cytokin
burden
induc
viral
infect
agonist
also
effect
adjuv
major
concern
use
agonist
toxic
associ
use
low
efficaci
use
therapeut
agent
instead
prophylact
agent
encapsul
within
liposom
shown
effect
mean
reduc
toxic
associ
free
drug
continu
work
develop
regim
agonist
therapi
requir
